BioNTech SE (ETR:22UA)
91.60
-0.55 (-0.60%)
Last updated: Jun 18, 2025
BioNTech SE Employees
BioNTech SE had 6,772 employees as of December 31, 2024. The number of employees increased by 639 or 10.42% compared to the previous year.
Employees
6,772
Change (1Y)
639
Growth (1Y)
10.42%
Revenue / Employee
€405,538
Profits / Employee
€113,113
Market Cap
21.90B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Siemens Healthineers AG | 72,000 |
Merck KGaA | 59,020 |
Bayer Aktiengesellschaft | 90,587 |
Fresenius SE & Co. KGaA | 176,486 |
Fresenius Medical Care AG | 111,513 |
Sartorius Aktiengesellschaft | 13,528 |
Carl Zeiss Meditec AG | 5,730 |
Fielmann Group AG | 24,363 |
BioNTech SE News
- 1 day ago - 5 Stocks To Ride The German Market Rally - Benzinga
- 3 days ago - Key deals this week: BioNTech, UnitedHealth, Qualcomm, Papa John's and more - Seeking Alpha
- 5 days ago - BioNTech's Acquisition Of CureVac Brings Complementary Method To Target Cancer - Seeking Alpha
- 5 days ago - BioNTech Expands mRNA Cancer Portfolio With CureVac $1.25 Billion All-Stock Deal - Benzinga
- 5 days ago - BioNTech Expands mRNA Cancer Portfolio With CureVac $1.25 Billion All-Stock Deal - Benzinga
- 5 days ago - CureVac, TELUS International, Oracle And Other Big Stocks Moving Higher On Thursday - Benzinga
- 5 days ago - COVID-19 Vaccine Maker BioNTech Buys CureVac as It Aims for Cancer Treatments - Investopedia
- 6 days ago - CVAC Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of CureVac N.V. Is Fair to Shareholders - Wallstreet:Online